Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Mar;64(3):1348-52.
doi: 10.1128/JVI.64.3.1348-1352.1990.

Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection

Affiliations

Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection

G R Nemerow et al. J Virol. 1990 Mar.

Abstract

Epstein-Barr virus (EBV), an oncogenic herpesvirus of humans, displays selective tropism for B lymphocytes and epithelial cells. EBV tropism is thought to be determined in part by a unique host cell receptor termed CR2 (CD21). Although previous studies have demonstrated that CR2 mediates EBV binding to B cells, its role in initiating EBV infection and B-cell transformation is less certain. In the studies reported here, soluble recombinant CR2 was shown to cause substantial inhibition of EBV infection of B cells in vitro, indicating that CR2 binding initiates EBV infection. Soluble CR2 may represent a therapeutic agent for acute and chronic EBV infections in humans.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1986 May;58(2):709-12 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8404-8 - PubMed
    1. J Virol. 1987 May;61(5):1416-20 - PubMed
    1. J Virol. 1987 Jun;61(6):1796-807 - PubMed
    1. Cell. 1987 Jul 17;50(2):203-13 - PubMed

Publication types

LinkOut - more resources